In some patients with chronic obstructive pulmonary disease (COPD), type 2 inflammation may increase exacerbation risk and may be indicated by elevated blood eosinophil counts. Dupilumab, a fully ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback